• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双苯并咪唑类化合物与羰基氰化物 3-氯苯腙联合对多重耐药菌的协同疗效。

Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.

机构信息

Chemical Biology laboratory, Department of Chemistry, University of Delhi, Delhi, India.

Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi, India.

出版信息

Sci Rep. 2017 Mar 17;7:44419. doi: 10.1038/srep44419.

DOI:10.1038/srep44419
PMID:28303897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5355889/
Abstract

Activation of efflux systems and the formation of biofilm are majorly adapted by microbes to resist antimicrobial agents. PPEF (bisbenzimidazole) targeting topoisomerase IA is observed to be an effective bactericidal agent against both Gram-positive and Gram-negative bacterial strains and thus can be developed as potent broad-spectrum antibiotic against MDR strains. PPEF treatment did not cause target specific mutation instead it leads to up-regulation of efflux gene in E. coli K12 as a mechanism of resistance. Microscopy, fluorescence spectroscopy and flow cytometry result demonstrate higher accumulation of PPEF in efflux gene deleted E. coli K12 mutants, and also suggest that Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP), resist the efflux of PPEF, and thus increases efficacy of PPEF. Herein, we report, PPEF and CCCP synergistically killed the persistent bacterial cells, which are not killed by PPEF alone. The above two compounds together inhibited biofilm formation, eradicate preformed biofilms and kills the biofilm cells of P. aeruginosa. PPEF and CCCP together reduced bacterial load of E. coli ATCC25922 by 6 log in neutropenic thigh infection model of balb/c mice. Present study suggests that combination therapy could be a promising antimicrobial strategy to handle MDR pathogenic strains.

摘要

微生物主要通过激活外排系统和形成生物膜来抵抗抗菌药物。我们观察到,靶向拓扑异构酶 IA 的 PPEF(苯并咪唑)是一种有效的杀菌剂,对革兰氏阳性和革兰氏阴性细菌菌株都有作用,因此可以开发为针对 MDR 菌株的有效广谱抗生素。PPEF 治疗不会导致特定的靶基因突变,而是导致大肠杆菌 K12 中外排基因的上调,作为一种耐药机制。显微镜、荧光光谱和流式细胞术结果表明,在删除外排基因的大肠杆菌 K12 突变体中,PPEF 的积累更高,并且还表明羰基氰化物 3-氯苯腙(CCCP)抵抗 PPEF 的外排,从而提高了 PPEF 的功效。在此,我们报告 PPEF 和 CCCP 协同杀死了持续性细菌细胞,这些细胞不能被 PPEF 单独杀死。这两种化合物共同抑制生物膜形成,根除已形成的生物膜并杀死铜绿假单胞菌的生物膜细胞。PPEF 和 CCCP 联合治疗可使 BALB/c 小鼠中性粒细胞减少性大腿感染模型中的大肠杆菌 ATCC25922 细菌负荷减少 6 个对数级。本研究表明,联合治疗可能是一种有前途的抗菌策略,可用于处理 MDR 致病性菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/4649c674f630/srep44419-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/d05a1c73ae13/srep44419-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/ec5413995498/srep44419-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/0a0ad62eaf1e/srep44419-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/fd5f2324aaf9/srep44419-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/08ad78cf80ea/srep44419-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/f0b3116e22e2/srep44419-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/4649c674f630/srep44419-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/d05a1c73ae13/srep44419-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/ec5413995498/srep44419-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/0a0ad62eaf1e/srep44419-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/fd5f2324aaf9/srep44419-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/08ad78cf80ea/srep44419-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/f0b3116e22e2/srep44419-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ec/5355889/4649c674f630/srep44419-f7.jpg

相似文献

1
Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.双苯并咪唑类化合物与羰基氰化物 3-氯苯腙联合对多重耐药菌的协同疗效。
Sci Rep. 2017 Mar 17;7:44419. doi: 10.1038/srep44419.
2
Synergistic Antimicrobial Activity of Colistin in Combination with Rifampin and Azithromycin against Escherichia coli Producing MCR-1.多黏菌素 E 与利福平及阿奇霉素联用对产 MCR-1 大肠杆菌的协同抗菌活性
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01631-18. Print 2018 Dec.
3
PPEF: A bisbenzimdazole potent antimicrobial agent interacts at acidic triad of catalytic domain of E. coli topoisomerase IA.PPEF:一种双苯并咪唑类强效抗菌剂与大肠杆菌拓扑异构酶 IA 催化结构域的酸性三联体相互作用。
Biochim Biophys Acta Gen Subj. 2019 Oct;1863(10):1524-1535. doi: 10.1016/j.bbagen.2019.05.015. Epub 2019 May 27.
4
Evaluation of chlorogenic acid and carnosol for anti-efflux pump and anti-biofilm activities against extensively drug-resistant strains of and .评价绿原酸和卡诺醇对广泛耐药株 和 的抗外排泵和抗生物膜活性。
Microbiol Spectr. 2024 Sep 3;12(9):e0393423. doi: 10.1128/spectrum.03934-23. Epub 2024 Jul 24.
5
Activity of carbonyl cyanide-3-chlorophenylhydrazone on biofilm formation and antimicrobial resistance in Pseudomonas aeruginosa using quantum dots-meropenem conjugates as nanotools.量子点-美罗培南偶联物作为纳米工具研究氰基-3-氯苯腙对铜绿假单胞菌生物膜形成和抗菌耐药性的影响
Methods Appl Fluoresc. 2020 Oct 6;8(4):045005. doi: 10.1088/2050-6120/aba7a2.
6
Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens.解析拓扑异构酶 IA 门控动力学在 PPEF 存在下的情况及其针对多药耐药病原体的临床前评估。
Commun Biol. 2023 Feb 18;6(1):195. doi: 10.1038/s42003-023-04412-1.
7
Exploring the contribution of efflux on the resistance to fluoroquinolones in clinical isolates of Escherichia coli.探讨外排泵对临床分离大肠杆菌耐氟喹诺酮类药物的作用。
Microb Drug Resist. 2013 Dec;19(6):469-76. doi: 10.1089/mdr.2013.0058. Epub 2013 Aug 2.
8
Butenolide, a Marine-Derived Broad-Spectrum Antibiofilm Agent Against Both Gram-Positive and Gram-Negative Pathogenic Bacteria.丁烯内脂,一种来源于海洋的广谱抗生物膜剂,可对抗革兰氏阳性和革兰氏阴性病原菌。
Mar Biotechnol (NY). 2019 Feb;21(1):88-98. doi: 10.1007/s10126-018-9861-1. Epub 2019 Jan 5.
9
Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.巴西耐碳青霉烯类鲍曼不动杆菌和铜绿假单胞菌菌株收集物的流行病学、生理学及分子特征
Microb Drug Resist. 2017 Oct;23(7):852-863. doi: 10.1089/mdr.2016.0219. Epub 2017 Feb 24.
10
From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.从乳腺癌到抗菌:利用多粘菌素B与选择性雌激素受体调节剂的新型组合对抗极具耐药性的革兰氏阴性“超级细菌”
Microb Drug Resist. 2017 Jul;23(5):640-650. doi: 10.1089/mdr.2016.0196. Epub 2016 Dec 9.

引用本文的文献

1
Adaptive laboratory-evolved MRSA with PPEF manifests cross-susceptibility to oxacillin and hypersensitivity to ciprofloxacin.具有PPEF的适应性实验室进化型耐甲氧西林金黄色葡萄球菌对苯唑西林表现出交叉敏感性,对环丙沙星表现出超敏反应。
Microbiol Spectr. 2025 Aug 5;13(8):e0297424. doi: 10.1128/spectrum.02974-24. Epub 2025 Jul 15.
2
Unraveling topoisomerase IA gate dynamics in presence of PPEF and its preclinical evaluation against multidrug-resistant pathogens.解析拓扑异构酶 IA 门控动力学在 PPEF 存在下的情况及其针对多药耐药病原体的临床前评估。
Commun Biol. 2023 Feb 18;6(1):195. doi: 10.1038/s42003-023-04412-1.
3
An antibacterial compound pyrimidomycin produced by Streptomyces sp. PSAA01 isolated from soil of Eastern Himalayan foothill.

本文引用的文献

1
Distinguishing between resistance, tolerance and persistence to antibiotic treatment.区分抗生素治疗的耐药性、耐受性和持久性。
Nat Rev Microbiol. 2016 Apr;14(5):320-30. doi: 10.1038/nrmicro.2016.34.
2
Potent Antibacterial Nanoparticles against Biofilm and Intracellular Bacteria.针对生物膜和细胞内细菌的强效抗菌纳米颗粒
Sci Rep. 2016 Jan 5;6:18877. doi: 10.1038/srep18877.
3
Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.外排泵抑制剂:一种对抗细菌外排介导耐药性的新方法。
从东喜马拉雅山麓土壤中分离得到的链霉菌 PSAA01 产生的一种抗菌化合物嘧啶霉素。
Sci Rep. 2022 Jun 17;12(1):10176. doi: 10.1038/s41598-022-14549-4.
4
Effect of new carbonyl cyanide aromatic hydrazones on biofilm inhibition against methicillin resistant .新型羰基氰化物芳香腙对耐甲氧西林生物膜抑制的作用
RSC Adv. 2020 May 7;10(30):17854-17861. doi: 10.1039/d0ra03124k. eCollection 2020 May 5.
5
Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.具有抗结核作用的潜在研究化合物和具有重新定位潜力的抗结核治疗药物:概述。
Appl Microbiol Biotechnol. 2020 Jul;104(13):5633-5662. doi: 10.1007/s00253-020-10606-y. Epub 2020 May 5.
6
Gram-negative synergy and mechanism of action of alkynyl bisbenzimidazoles.炔基双苯并咪唑的革兰氏阴性协同作用和作用机制。
Sci Rep. 2019 Oct 2;9(1):14171. doi: 10.1038/s41598-019-48898-4.
Curr Drug Targets. 2016;17(6):702-19. doi: 10.2174/1389450116666151001103948.
4
Critical aspects of using bacterial cell viability assays with the fluorophores SYTO9 and propidium iodide.使用荧光染料SYTO9和碘化丙啶进行细菌细胞活力测定的关键方面。
BMC Microbiol. 2015 Feb 18;15:36. doi: 10.1186/s12866-015-0376-x.
5
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.生物膜相关感染:弥合临床管理与对抗生素顽固性的基本方面之间的差距。
Microbiol Mol Biol Rev. 2014 Sep;78(3):510-43. doi: 10.1128/MMBR.00013-14.
6
Bacterial multidrug efflux pumps: mechanisms, physiology and pharmacological exploitations.细菌多药外排泵:机制、生理学及药理学应用
Biochem Biophys Res Commun. 2014 Oct 17;453(2):254-67. doi: 10.1016/j.bbrc.2014.05.090. Epub 2014 May 27.
7
Synthesis and biological evaluation of novel bisbenzimidazoles as Escherichia coli topoisomerase IA inhibitors and potential antibacterial agents.新型双苯并咪唑的合成及生物评价作为大肠埃希菌拓扑异构酶 IA 抑制剂和潜在的抗菌剂。
J Med Chem. 2014 Jun 26;57(12):5238-57. doi: 10.1021/jm5003028. Epub 2014 Jun 4.
8
Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms.细菌和真菌生物膜中抗菌药物耐受和耐药的分子机制。
Trends Microbiol. 2014 Jun;22(6):326-33. doi: 10.1016/j.tim.2014.02.001. Epub 2014 Mar 2.
9
Esculentin(1-21), an amphibian skin membrane-active peptide with potent activity on both planktonic and biofilm cells of the bacterial pathogen Pseudomonas aeruginosa.Esculentin(1-21),一种来自两栖动物皮肤的膜活性肽,对细菌病原体铜绿假单胞菌的浮游细胞和生物膜细胞均具有强大的活性。
Cell Mol Life Sci. 2013 Aug;70(15):2773-86. doi: 10.1007/s00018-013-1291-7. Epub 2013 Mar 16.
10
Clinical relevance of the ESKAPE pathogens.ESKAPE 病原体的临床相关性。
Expert Rev Anti Infect Ther. 2013 Mar;11(3):297-308. doi: 10.1586/eri.13.12.